Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 6, 2026

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

HLA-B*5701 testing to predict abacavir hypersensitivity.

Joseph D Ma¹, Kelly C Lee, Grace M Kuo

¹University of California, San Diego, Skaggs School of Pharmacy & Pharmaceutical Sciences and University of California, San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences.

|December 15, 2010

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Elephant in the Room: Reckoning With Collegiality and Authorship in Academic Pharmacy.

American journal of pharmaceutical education·2026

Same author

As-Needed Medication Use for Agitation Across Valproic Acid Formulations.

Current therapeutic research, clinical and experimental·2026

Same author

Assessment of Curricular Integration of Compassionate Communication in Pharmacy Training.

American journal of pharmaceutical education·2026

Same author

Assessment of the Intestinal CYP3A Contribution to Drug Interactions with Extended-Release Tacrolimus (LCPT) Using Grapefruit Juice.

Clinical pharmacology in drug development·2026

Same author

Collaborative development of a shared objective structured clinical examination to assess the pharmacist patient care process across two PharmD programs.

Currents in pharmacy teaching & learning·2026

Same author

National trends in pharmacist and pharmacy technician suicide: Incidence and associated features.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

Same journal

Measuring Mosquito-borne Viral Suitability in Myanmar and Implications for Local Zika Virus Transmission.

PLoS currents·2019

Same journal

Drought in the Semiarid Region of Brazil: Exposure, Vulnerabilities and Health Impacts from the Perspectives of Local Actors.

PLoS currents·2018

Same journal

Estimation of Pneumonic Plague Transmission in Madagascar, August-November 2017.

PLoS currents·2018

Same journal

Does the Humanitarian Sector Use Evidence-informed Standards? A Review of the 2011 Sphere Indicators for Wash, Food Security and Nutrition, and Health Action.

PLoS currents·2018

Same journal

Uganda at Glance of 5.7 Magnitude Earthquake: Lessons for Earthquake Risk Reduction.

PLoS currents·2018

Same journal

Neurodevelopmental Needs in Young Boys with Duchenne Muscular Dystrophy (DMD): Observations from the Cooperative International Neuromuscular Research Group (CINRG) DMD Natural History Study (DNHS).

PLoS currents·2018

See all related articles

Abacavir hypersensitivity reactions, a severe side effect of HIV treatment, are linked to the HLA-B*5701 gene. Screening for this allele helps identify patients at risk, improving safety for abacavir therapy.

Area of Science:

Pharmacogenomics
Immunology
Infectious Diseases

Background:

Abacavir is a crucial antiretroviral medication for HIV treatment.
Hypersensitivity reactions (HVR) to abacavir can be severe and life-threatening.
The HLA-B*5701 allele is strongly associated with abacavir-induced HVR.

Purpose of the Study:

To highlight the association between HLA-B*5701 and abacavir hypersensitivity.
To emphasize the clinical utility of HLA-B*5701 screening.
To improve patient safety in HIV therapy.

Main Methods:

Review of clinical data and genetic association studies.
Analysis of adverse event reports related to abacavir.
Discussion of diagnostic screening strategies.

More Related Videos

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

Related Experiment Videos

Last Updated: Jun 6, 2026

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

Main Results:

The presence of the HLA-B*5701 allele is a significant risk factor for abacavir HVR.
Pre-treatment screening for HLA-B*5701 can identify at-risk individuals.
Avoiding abacavir in HLA-B*5701 positive patients prevents HVR.

Conclusions:

HLA-B*5701 screening is essential before initiating abacavir therapy.
Genetic screening enhances the safe use of abacavir in HIV management.
Personalized medicine approaches improve treatment outcomes and patient safety.